| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 | 2.02e-14 | 67 | 133 | 12 | GO:0031492 |
| GeneOntologyMolecularFunction | nucleosome binding | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 | 2.30e-12 | 98 | 133 | 12 | GO:0031491 |
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 6.45e-11 | 100 | 133 | 11 | GO:0030527 |
| GeneOntologyMolecularFunction | chromatin DNA binding | H2AC11 PER1 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 | 9.17e-11 | 167 | 133 | 13 | GO:0031490 |
| GeneOntologyMolecularFunction | chromatin binding | H2AC11 POLR1A PDX1 PER1 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 SCML2 PRDM11 UBE2T H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 DNMT3B | 4.57e-07 | 739 | 133 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 ARNT2 H2AC7 H2AX H2AJ H2AC12 | 1.46e-05 | 398 | 133 | 12 | GO:0046982 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.94e-05 | 171 | 133 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.46e-05 | 52 | 133 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | structural molecule activity | H2AC11 NID2 KRT7 COL16A1 TNC H2AC21 H2AC6 H2AC4 H2AC18 THBS2 H2AC20 H2AC1 H2AC7 H2AX H2AJ TNXB H2AC12 DCTN3 | 2.61e-05 | 891 | 133 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.30e-04 | 167 | 133 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | smoothened binding | 2.62e-04 | 4 | 133 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 3.79e-04 | 199 | 133 | 7 | GO:1901981 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 4.36e-04 | 95 | 133 | 5 | GO:0005546 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 6.49e-04 | 6 | 133 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 7.52e-04 | 27 | 133 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.28e-03 | 316 | 133 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 1.30e-03 | 121 | 133 | 5 | GO:1902936 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.67e-03 | 128 | 133 | 5 | GO:0005267 | |
| GeneOntologyMolecularFunction | RNA polymerase I activity | 1.91e-03 | 10 | 133 | 2 | GO:0001054 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.91e-03 | 10 | 133 | 2 | GO:0005222 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX H2AJ H2AC12 DNMT3B | 5.51e-11 | 163 | 135 | 13 | GO:0031507 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX H2AJ H2AC12 DNMT3B | 8.45e-10 | 203 | 135 | 13 | GO:0045814 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX H2AJ SGF29 H2AC12 DNMT3B | 3.65e-08 | 330 | 135 | 14 | GO:0040029 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2AC11 PER1 H2AC21 MECOM H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX SMARCC1 H2AJ PRKDC SGF29 H2AC12 DNMT3B | 1.67e-06 | 741 | 135 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | H2AC11 PER1 H2AC21 MECOM H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX SMARCC1 H2AJ PRKDC SGF29 H2AC12 DNMT3B | 2.26e-05 | 896 | 135 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 6.66e-05 | 105 | 135 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2AC11 PER1 H2AC21 MECOM H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX SMARCC1 H2AJ PRKDC SGF29 H2AC12 DNMT3B | 9.22e-05 | 999 | 135 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 1.48e-04 | 438 | 135 | 11 | GO:1902903 | |
| GeneOntologyCellularComponent | nucleosome | H2AC11 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.55e-09 | 138 | 135 | 11 | GO:0000786 |
| GeneOntologyCellularComponent | stereocilium | 8.41e-05 | 69 | 135 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | stereocilium bundle | 1.60e-04 | 79 | 135 | 5 | GO:0032421 | |
| GeneOntologyCellularComponent | HCN channel complex | 2.46e-04 | 4 | 135 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | tenascin complex | 2.46e-04 | 4 | 135 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | XY body | 4.24e-04 | 23 | 135 | 3 | GO:0001741 | |
| GeneOntologyCellularComponent | actin-based cell projection | 4.57e-04 | 278 | 135 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.75e-04 | 59 | 135 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 6.11e-04 | 6 | 135 | 2 | GO:0032983 | |
| MousePheno | abnormal cochlear hair cell inter-stereocilial links morphology | 2.72e-05 | 9 | 98 | 3 | MP:0004577 | |
| MousePheno | decreased cochlear hair cell stereocilia number | 3.02e-05 | 26 | 98 | 4 | MP:0004523 | |
| Domain | HISTONE_H2A | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 6.16e-19 | 21 | 135 | 11 | PS00046 |
| Domain | Histone_H2A | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.33e-18 | 23 | 135 | 11 | IPR002119 |
| Domain | H2A | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.33e-18 | 23 | 135 | 11 | SM00414 |
| Domain | Histone_H2A_CS | 1.98e-16 | 15 | 135 | 9 | IPR032458 | |
| Domain | Histone_H2A_C | 9.51e-16 | 17 | 135 | 9 | IPR032454 | |
| Domain | Histone_H2A_C | 9.51e-16 | 17 | 135 | 9 | PF16211 | |
| Domain | Histone_H2A/H2B/H3 | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.10e-13 | 56 | 135 | 11 | IPR007125 |
| Domain | Histone | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.10e-13 | 56 | 135 | 11 | PF00125 |
| Domain | Histone-fold | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.93e-11 | 83 | 135 | 11 | IPR009072 |
| Domain | - | 1.62e-09 | 69 | 135 | 9 | 1.10.20.10 | |
| Domain | FerA | 1.55e-04 | 3 | 135 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 1.55e-04 | 3 | 135 | 2 | IPR012560 | |
| Domain | FerA | 1.55e-04 | 3 | 135 | 2 | PF08165 | |
| Domain | fn3 | 1.77e-04 | 162 | 135 | 7 | PF00041 | |
| Domain | Ion_trans_N | 3.08e-04 | 4 | 135 | 2 | IPR013621 | |
| Domain | DysFC | 3.08e-04 | 4 | 135 | 2 | SM00694 | |
| Domain | DysFN | 3.08e-04 | 4 | 135 | 2 | SM00693 | |
| Domain | Ion_trans_N | 3.08e-04 | 4 | 135 | 2 | PF08412 | |
| Domain | Peroxin/Ferlin | 3.08e-04 | 4 | 135 | 2 | IPR006614 | |
| Domain | EGF | 3.09e-04 | 126 | 135 | 6 | PF00008 | |
| Domain | FN3 | 3.98e-04 | 185 | 135 | 7 | SM00060 | |
| Domain | FerI | 5.11e-04 | 5 | 135 | 2 | SM01202 | |
| Domain | FerB | 5.11e-04 | 5 | 135 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 5.11e-04 | 5 | 135 | 2 | IPR012561 | |
| Domain | Ferlin_C | 5.11e-04 | 5 | 135 | 2 | PF16165 | |
| Domain | Ferlin_C | 5.11e-04 | 5 | 135 | 2 | IPR032362 | |
| Domain | FerIin_dom | 5.11e-04 | 5 | 135 | 2 | IPR012968 | |
| Domain | FerI | 5.11e-04 | 5 | 135 | 2 | PF08151 | |
| Domain | FerB | 5.11e-04 | 5 | 135 | 2 | PF08150 | |
| Domain | FN3 | 6.15e-04 | 199 | 135 | 7 | PS50853 | |
| Domain | FG-GAP | 6.69e-04 | 24 | 135 | 3 | PF01839 | |
| Domain | FG-GAP | 6.69e-04 | 24 | 135 | 3 | IPR013517 | |
| Domain | DCX | 7.63e-04 | 6 | 135 | 2 | SM00537 | |
| Domain | FN3_dom | 8.22e-04 | 209 | 135 | 7 | IPR003961 | |
| Domain | - | 1.06e-03 | 7 | 135 | 2 | 3.10.20.230 | |
| Domain | DCX | 1.06e-03 | 7 | 135 | 2 | PF03607 | |
| Domain | Chorein_N | 1.41e-03 | 8 | 135 | 2 | PF12624 | |
| Domain | DC | 1.41e-03 | 8 | 135 | 2 | PS50309 | |
| Domain | VPS13_N | 1.41e-03 | 8 | 135 | 2 | IPR026854 | |
| Domain | Doublecortin_dom | 1.41e-03 | 8 | 135 | 2 | IPR003533 | |
| Domain | EGF | 1.62e-03 | 235 | 135 | 7 | SM00181 | |
| Domain | EGF-like_dom | 2.24e-03 | 249 | 135 | 7 | IPR000742 | |
| Domain | EGF_dom | 3.26e-03 | 12 | 135 | 2 | IPR024731 | |
| Domain | EGF_3 | 3.26e-03 | 12 | 135 | 2 | PF12947 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.46e-03 | 14 | 135 | 2 | IPR003938 | |
| Domain | - | 5.00e-03 | 95 | 135 | 4 | 2.60.120.200 | |
| Domain | Pept_M10A_Zn_BS | 5.12e-03 | 15 | 135 | 2 | IPR021158 | |
| Domain | Growth_fac_rcpt_ | 5.54e-03 | 156 | 135 | 5 | IPR009030 | |
| Domain | cNMP-bd_CS | 5.82e-03 | 16 | 135 | 2 | IPR018488 | |
| Domain | Integrin_alpha_C_CS | 5.82e-03 | 16 | 135 | 2 | IPR018184 | |
| Domain | Kinase-like_dom | CDC42BPA MYLK MAP3K6 MAP3K3 FN3K TIE1 FES MAP3K9 SMARCC1 PRKDC | 6.04e-03 | 542 | 135 | 10 | IPR011009 |
| Domain | Hemopexin_CS | 6.57e-03 | 17 | 135 | 2 | IPR018486 | |
| Domain | Quinoprotein_ADH-like_supfam | 6.65e-03 | 53 | 135 | 3 | IPR011047 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 | 7.87e-14 | 78 | 119 | 13 | M27234 |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 3.60e-13 | 37 | 119 | 10 | M27580 |
| Pathway | REACTOME_UCH_PROTEINASES | H2AC11 PSMC4 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 9.06e-10 | 102 | 119 | 11 | M27576 |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.25e-09 | 40 | 119 | 8 | MM14936 | |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | POLR1A POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ DNMT3B | 1.68e-09 | 108 | 119 | 11 | M27426 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.02e-09 | 139 | 119 | 12 | M4741 |
| Pathway | REACTOME_DNA_METHYLATION | 2.99e-09 | 64 | 119 | 9 | M27429 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 3.42e-09 | 29 | 119 | 7 | MM15291 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | POLR1A POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 4.06e-09 | 90 | 119 | 10 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | POLR1A POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 4.06e-09 | 90 | 119 | 10 | M29668 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 4.55e-09 | 67 | 119 | 9 | M39003 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 6.24e-09 | 94 | 119 | 10 | M27230 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 8.74e-09 | 72 | 119 | 9 | M27132 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2AC11 H2AC21 MECOM H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ SGF29 H2AC12 | 8.95e-09 | 272 | 119 | 15 | M29619 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | 1.78e-08 | 55 | 119 | 8 | M29526 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | POLR1A POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 1.84e-08 | 105 | 119 | 10 | M27425 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | POLR1A POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 2.89e-08 | 110 | 119 | 10 | M27696 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 SGF29 H2AC12 | 3.06e-08 | 142 | 119 | 11 | M27233 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 3.14e-08 | 39 | 119 | 7 | MM14850 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 4.70e-08 | 62 | 119 | 8 | M27700 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 4.82e-08 | 116 | 119 | 10 | M29806 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | ST3GAL4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMED2 H2AJ | 6.16e-08 | 119 | 119 | 10 | M607 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 6.39e-08 | 90 | 119 | 9 | M2158 | |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | 7.76e-08 | 66 | 119 | 8 | M27488 | |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | 8.76e-08 | 67 | 119 | 8 | M27342 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | 9.85e-08 | 68 | 119 | 8 | M27658 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 1.23e-07 | 97 | 119 | 9 | M48262 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | 1.24e-07 | 70 | 119 | 8 | M48261 | |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.24e-07 | 70 | 119 | 8 | M48028 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.55e-07 | 72 | 119 | 8 | M29714 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.73e-07 | 73 | 119 | 8 | M27166 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 1.98e-07 | 31 | 119 | 6 | MM17225 | |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | 2.14e-07 | 75 | 119 | 8 | M27343 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | POLR1A POLR2E H2AC6 H2AC4 H2AC18 H2AC20 H2AX H2AJ SGF29 DNMT3B | 2.18e-07 | 136 | 119 | 10 | MM14848 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | POLR1A POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX SMARCC1 H2AJ SGF29 DNMT3B | 2.22e-07 | 254 | 119 | 13 | M27131 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | 2.25e-07 | 104 | 119 | 9 | M29829 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 2.50e-07 | 138 | 119 | 10 | M29805 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.65e-07 | 106 | 119 | 9 | M27458 | |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | 2.91e-07 | 78 | 119 | 8 | M1061 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 3.22e-07 | 79 | 119 | 8 | M27191 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 3.71e-07 | 55 | 119 | 7 | MM14932 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 4.26e-07 | 112 | 119 | 9 | M4052 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ FKBP4 | 5.11e-07 | 149 | 119 | 10 | M27888 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 5.98e-07 | 37 | 119 | 6 | MM14883 | |
| Pathway | REACTOME_UCH_PROTEINASES | 6.82e-07 | 87 | 119 | 8 | MM15287 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 7.06e-07 | 38 | 119 | 6 | MM15434 | |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | 7.45e-07 | 88 | 119 | 8 | M1011 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 8.13e-07 | 89 | 119 | 8 | M27943 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 8.80e-07 | 122 | 119 | 9 | M29689 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.64e-07 | 91 | 119 | 8 | M27101 | |
| Pathway | REACTOME_HCMV_INFECTION | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 1.10e-06 | 162 | 119 | 10 | M29804 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 1.14e-06 | 93 | 119 | 8 | M27487 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 1.41e-06 | 129 | 119 | 9 | M27795 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.45e-06 | 96 | 119 | 8 | M27792 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 1.46e-06 | 67 | 119 | 7 | MM15429 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.73e-06 | 44 | 119 | 6 | MM15527 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ MMP2 FKBP4 | 2.51e-06 | 220 | 119 | 11 | M27794 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2AC11 PSMC4 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 2.62e-06 | 221 | 119 | 11 | M27578 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 2.62e-06 | 139 | 119 | 9 | M868 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.62e-06 | 139 | 119 | 9 | M715 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.13e-06 | 142 | 119 | 9 | M48257 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 3.31e-06 | 107 | 119 | 8 | M48260 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 3.74e-06 | 50 | 119 | 6 | MM15308 | |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | 4.07e-06 | 110 | 119 | 8 | M27958 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 4.35e-06 | 111 | 119 | 8 | M27187 | |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | 4.66e-06 | 112 | 119 | 8 | M48334 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 5.92e-06 | 54 | 119 | 6 | MM14904 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | PSMC4 ST3GAL4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMED2 H2AJ | 7.33e-06 | 246 | 119 | 11 | M10189 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 7.33e-06 | 56 | 119 | 6 | MM17236 | |
| Pathway | REACTOME_MEIOSIS | 7.78e-06 | 120 | 119 | 8 | M529 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 7.91e-06 | 159 | 119 | 9 | M27665 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.05e-05 | 125 | 119 | 8 | M27186 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.25e-05 | 128 | 119 | 8 | M48019 | |
| Pathway | REACTOME_DNA_REPAIR | POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 ADPRS UBE2T H2AC7 H2AX H2AJ PRKDC | 2.37e-05 | 332 | 119 | 12 | M15434 |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.66e-05 | 142 | 119 | 8 | M27660 | |
| Pathway | REACTOME_DNA_REPLICATION | 2.89e-05 | 187 | 119 | 9 | M1017 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | PSMC4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX SMARCC1 H2AJ | 3.20e-05 | 237 | 119 | 10 | M27786 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 3.70e-05 | 74 | 119 | 6 | MM14605 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | POLR2E H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ MMP2 FKBP4 | 4.10e-05 | 296 | 119 | 11 | M27869 |
| Pathway | REACTOME_DEUBIQUITINATION | H2AC11 PSMC4 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 4.49e-05 | 299 | 119 | 11 | M27574 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 4.54e-05 | 153 | 119 | 8 | MM15522 | |
| Pathway | REACTOME_REPRODUCTION | 5.71e-05 | 158 | 119 | 8 | M26956 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.17e-04 | 175 | 119 | 8 | MM14941 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.58e-04 | 233 | 119 | 9 | M27099 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 2.13e-04 | 191 | 119 | 8 | MM15289 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 2.22e-04 | 102 | 119 | 6 | MM15430 | |
| Pathway | REACTOME_DNA_REPAIR | POLR2E H2AC6 H2AC4 H2AC18 H2AC20 ADPRS UBE2T H2AX H2AJ PRKDC | 2.32e-04 | 301 | 119 | 10 | MM15433 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 2.63e-04 | 197 | 119 | 8 | M27188 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.05e-04 | 114 | 119 | 6 | MM15361 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 4.06e-04 | 323 | 119 | 10 | M27080 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.09e-04 | 119 | 119 | 6 | MM14901 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | H2AC11 NT5E POLR2E PSMC4 H2AC21 ST3GAL4 MAGT1 ADCY6 TXNIP H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MGAT1 H2AC1 SEC11A H2AC7 FKBP4 H2AC12 | 6.85e-04 | 1081 | 119 | 20 | M27548 |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | H2AC11 POLR2E PSMC4 H2AC21 ST3GAL4 MAGT1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MGAT1 H2AC1 SEC11A H2AC7 FKBP4 H2AC12 | 1.24e-03 | 888 | 119 | 17 | M48034 |
| Pathway | KEGG_PYRIMIDINE_METABOLISM | 1.43e-03 | 98 | 119 | 5 | M5109 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.54e-03 | 258 | 119 | 8 | MM14572 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.70e-03 | 262 | 119 | 8 | MM15286 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.92e-03 | 330 | 119 | 9 | M7847 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.96e-03 | 63 | 119 | 4 | MM15613 | |
| Pathway | KEGG_PURINE_METABOLISM | 2.28e-03 | 159 | 119 | 6 | M14314 | |
| Pathway | REACTOME_M_PHASE | PSMC4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ DCTN3 | 2.78e-03 | 417 | 119 | 10 | M27662 |
| Pubmed | H2AC11 POLR2E H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.54e-17 | 86 | 139 | 13 | 11080476 | |
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 SYNCRIP | 3.48e-17 | 88 | 139 | 13 | 26318153 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 7.42e-17 | 69 | 139 | 12 | 11689053 |
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.53e-16 | 73 | 139 | 12 | 14657027 | |
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.53e-16 | 73 | 139 | 12 | 9566873 | |
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.82e-16 | 74 | 139 | 12 | 36180920 | |
| Pubmed | DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A. | 4.55e-15 | 11 | 139 | 7 | 16702407 | |
| Pubmed | 4.55e-15 | 11 | 139 | 7 | 15078818 | ||
| Pubmed | Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. | 2.35e-14 | 13 | 139 | 7 | 15823041 | |
| Pubmed | 1.55e-13 | 16 | 139 | 7 | 15386022 | ||
| Pubmed | 2.89e-13 | 30 | 139 | 8 | 16319397 | ||
| Pubmed | Phosphorylation of histone H2A inhibits transcription on chromatin templates. | 4.29e-13 | 18 | 139 | 7 | 15010469 | |
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 6.54e-13 | 77 | 139 | 10 | 12408966 | |
| Pubmed | Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. | 6.77e-13 | 19 | 139 | 7 | 16359901 | |
| Pubmed | H2AC11 AAMP KRT7 PUF60 PSMC4 H2AC21 SSR4 RRM1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ PRKDC METTL16 ALDOC SNRNP200 ATP4A H2AC12 SYNCRIP | 5.27e-12 | 1153 | 139 | 25 | 29845934 | |
| Pubmed | Precise characterization of human histones in the H2A gene family by top down mass spectrometry. | 1.07e-11 | 14 | 139 | 6 | 16457589 | |
| Pubmed | H2AC11 PUF60 H2AC21 SSR4 PFN2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 SEC11A H2AC7 H2AX H2AJ PRKDC ALDOC SNRNP200 FKBP4 H2AC12 SYNCRIP | 2.59e-11 | 844 | 139 | 21 | 25963833 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2AC11 ITGA6 PFN2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AJ PRKDC SNRNP200 FKBP4 H2AC12 SYNCRIP | 9.49e-10 | 477 | 139 | 15 | 31300519 |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.06e-09 | 116 | 139 | 9 | 22810585 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2AC11 AAMP POLR1A POLR2E PSMC4 SSR4 MAGT1 RRM1 PFN2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SEC11A H2AC7 H2AX FIP1L1 H2AJ PRKDC SNRNP200 H2AC12 SYNCRIP | 1.12e-09 | 1257 | 139 | 23 | 37317656 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | H2AC11 NID2 KRT7 NT5E CAPG H2AC21 DYSF MYOF H2AC6 H2AC4 SAA1 H2AC18 H2AC20 MGAT1 H2AC1 H2AC7 H2AX H2AJ ALDOC TNXB H2AC12 | 1.89e-09 | 1070 | 139 | 21 | 23533145 |
| Pubmed | 2.42e-09 | 55 | 139 | 7 | 9439656 | ||
| Pubmed | 3.64e-09 | 6 | 139 | 4 | 15509584 | ||
| Pubmed | Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. | 8.47e-09 | 7 | 139 | 4 | 16699504 | |
| Pubmed | 1.18e-07 | 12 | 139 | 4 | 15525528 | ||
| Pubmed | H2AC21 H2AC14 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AJ PRKDC ALDOC SNRNP200 H2AC12 SYNCRIP | 1.62e-07 | 513 | 139 | 13 | 25798074 | |
| Pubmed | Quantitative determination of histone modification. H2A acetylation and phosphorylation. | 2.49e-07 | 4 | 139 | 3 | 7217105 | |
| Pubmed | 2.99e-07 | 67 | 139 | 6 | 25253489 | ||
| Pubmed | KRT7 MYLK MYO1A DDX42 H2AC21 ADCY6 TBCB H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ PRKDC H2AC12 SYNCRIP DNMT3B | 3.03e-07 | 1442 | 139 | 21 | 35575683 | |
| Pubmed | H2AC11 AAMP H2AC21 RRM1 TBCB H2AC14 H2AC6 H2AC4 H2AC1 PDXP H2AC7 H2AX TMED2 H2AJ PRKDC H2AC12 | 4.99e-07 | 878 | 139 | 16 | 37223481 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 H2AC11 AAMP PUF60 ITGA6 PSMC4 MAGT1 RRM1 PFN2 GPKOW TBCB MYOF H2AC4 H2AC18 UBE2T SMARCC1 TMED2 PRKDC M6PR FKBP4 | 5.58e-07 | 1367 | 139 | 20 | 32687490 |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.32e-06 | 86 | 139 | 6 | 28327460 | |
| Pubmed | H2AC11 KRT7 PSMC4 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX | 1.64e-06 | 438 | 139 | 11 | 21630459 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 2.16e-06 | 7 | 139 | 3 | 8858345 | |
| Pubmed | RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. | 2.16e-06 | 7 | 139 | 3 | 22980979 | |
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 11767049 | ||
| Pubmed | POLR1A NT5E POLR2E DDX42 PSMC4 H2AC21 PPWD1 MYOF H2AC6 H2AX PRKDC SNRNP200 H2AC12 | 2.69e-06 | 660 | 139 | 13 | 32780723 | |
| Pubmed | H2AC11 FAM234A NT5E CAPG SSR4 H2AC18 H2AC20 H2AC7 H2AJ ALDOC FKBP4 H2AC12 | 3.09e-06 | 565 | 139 | 12 | 20458337 | |
| Pubmed | The genomic organization of the histone clusters on human 6p21.3. | 5.16e-06 | 9 | 139 | 3 | 10384058 | |
| Pubmed | 7.31e-06 | 247 | 139 | 8 | 30713523 | ||
| Pubmed | The doublecortin gene family and disorders of neuronal structure. | 7.34e-06 | 10 | 139 | 3 | 20236041 | |
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 16869982 | ||
| Pubmed | 7.98e-06 | 250 | 139 | 8 | 33536335 | ||
| Pubmed | Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. | 1.01e-05 | 11 | 139 | 3 | 26237645 | |
| Pubmed | POLR2E H2AC21 SSR4 H2AC14 H2AC6 H2AC1 H2AC7 H2AX TMED2 PRKDC SNRNP200 SYNCRIP | 1.30e-05 | 652 | 139 | 12 | 31180492 | |
| Pubmed | POLR1A PUF60 CAPG POLR2E DDX42 GPKOW PPWD1 H2AC4 UBE2T SMARCC1 FIP1L1 PRKDC METTL16 FKBP4 H2AC12 | 1.42e-05 | 1014 | 139 | 15 | 32416067 | |
| Pubmed | Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. | 1.59e-05 | 2 | 139 | 2 | 11959863 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34354129 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9321695 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32839504 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29164766 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 1.59e-05 | 2 | 139 | 2 | 17548059 | |
| Pubmed | Rhythmic interaction between Period1 mRNA and hnRNP Q leads to circadian time-dependent translation. | 1.59e-05 | 2 | 139 | 2 | 22124155 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20855890 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19901909 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17202312 | ||
| Pubmed | DNA-PK is responsible for enhanced phosphorylation of histone H2AX under hypertonic conditions. | 1.59e-05 | 2 | 139 | 2 | 16046194 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28055960 | ||
| Pubmed | Role of fibrillar Tenascin-C in metastatic pancreatic cancer. | 1.59e-05 | 2 | 139 | 2 | 19287959 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15455729 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7509489 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31715134 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 1.59e-05 | 2 | 139 | 2 | 23882691 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15212943 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21364666 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31004665 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18062933 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21456027 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8856503 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 1.59e-05 | 2 | 139 | 2 | 11675786 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19228595 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 36608439 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33795696 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18495154 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25815686 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11948127 | ||
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 1.59e-05 | 2 | 139 | 2 | 12359049 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19135060 | ||
| Pubmed | The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia. | 1.59e-05 | 2 | 139 | 2 | 22295105 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31192258 | ||
| Pubmed | Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. | 1.59e-05 | 2 | 139 | 2 | 22465227 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 36980257 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25494902 | ||
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 1.59e-05 | 2 | 139 | 2 | 9013311 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15820310 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 30725116 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | POLR2E TRIOBP PSMC4 H2AC21 SSR4 H2AC4 H2AC20 PRKDC SNRNP200 FKBP4 H2AC12 | 2.06e-05 | 573 | 139 | 11 | 28330616 |
| Pubmed | 2.20e-05 | 14 | 139 | 3 | 10064132 | ||
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 2.74e-05 | 15 | 139 | 3 | 18855897 | |
| Pubmed | 2.74e-05 | 15 | 139 | 3 | 21147989 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H2AC11 POLR1A PUF60 SSR4 H2AC14 H2AC18 H2AC20 H2AC7 FIP1L1 H2AJ PRKDC SNRNP200 H2AC12 SYNCRIP | 2.88e-05 | 949 | 139 | 14 | 36574265 |
| Pubmed | UBR1 POLR1A PUF60 POLR2E DDX42 SMARCC1 METTL16 SNRNP200 SYNCRIP | 2.91e-05 | 390 | 139 | 9 | 17643375 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 3.01e-05 | 219 | 139 | 7 | 31353912 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CDC42BPA PUF60 DDX42 TRIOBP SSR4 SBF1 SEC11A RBM15B SMARCC1 FIP1L1 PRKDC SNRNP200 TNXB SYNCRIP DNMT3B | 3.02e-05 | 1082 | 139 | 15 | 38697112 |
| Pubmed | 3.28e-05 | 222 | 139 | 7 | 35941108 | ||
| Pubmed | 3.33e-05 | 305 | 139 | 8 | 33194618 | ||
| Pubmed | 3.37e-05 | 16 | 139 | 3 | 17567809 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | PUF60 DDX42 MECOM H2AC20 RBM15B SMARCC1 FIP1L1 PRKDC SNRNP200 H2AC12 SYNCRIP | 3.38e-05 | 605 | 139 | 11 | 28977666 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | H2AC11 POLR1A DDX42 PSMC4 RRM1 H2AC4 UBE2T SMARCC1 PRKDC ALDOC SNRNP200 FKBP4 DCTN3 | 3.76e-05 | 847 | 139 | 13 | 35235311 |
| Pubmed | GPHN PUF60 PSMC4 PFN2 GPKOW LSM1 H2AC1 SMARCC1 SNRNP200 H2AC12 | 3.89e-05 | 506 | 139 | 10 | 30890647 | |
| Interaction | H2AC1 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.73e-12 | 71 | 137 | 11 | int:H2AC1 |
| Interaction | H2AC13 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 8.61e-11 | 75 | 137 | 10 | int:H2AC13 |
| Interaction | LOC102724334 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.24e-10 | 134 | 137 | 12 | int:LOC102724334 |
| Interaction | H2AC7 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 1.70e-10 | 107 | 137 | 11 | int:H2AC7 |
| Interaction | H2BC17 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.08e-10 | 140 | 137 | 12 | int:H2BC17 |
| Interaction | H2BC15 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.89e-10 | 144 | 137 | 12 | int:H2BC15 |
| Interaction | H2BC18 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 | 3.04e-10 | 180 | 137 | 13 | int:H2BC18 |
| Interaction | H2AC12 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 4.92e-10 | 118 | 137 | 11 | int:H2AC12 |
| Interaction | H2AC6 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 1.56e-09 | 100 | 137 | 10 | int:H2AC6 |
| Interaction | HEXIM1 interactions | H2AC11 AAMP KRT7 PUF60 DDX42 PSMC4 H2AC21 RRM1 GPKOW H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ PRKDC ALDOC SNRNP200 ATP4A H2AC12 SYNCRIP | 2.37e-09 | 913 | 137 | 25 | int:HEXIM1 |
| Interaction | H2BC3 interactions | H2AC11 POLR1A POLR2E H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SCML2 H2AC1 H2AC7 H2AX H2AJ PRKDC H2AC12 SYNCRIP | 2.46e-09 | 406 | 137 | 17 | int:H2BC3 |
| Interaction | H2AC14 interactions | H2AC21 DMXL1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 4.14e-09 | 144 | 137 | 11 | int:H2AC14 |
| Interaction | H2BC26 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 4.54e-09 | 183 | 137 | 12 | int:H2BC26 |
| Interaction | H2BC11 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 5.45e-09 | 186 | 137 | 12 | int:H2BC11 |
| Interaction | H2AC18 interactions | H2AC11 ATG2A H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 5.53e-09 | 148 | 137 | 11 | int:H2AC18 |
| Interaction | H2AC25 interactions | 5.69e-09 | 84 | 137 | 9 | int:H2AC25 | |
| Interaction | H2AJ interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 1.61e-08 | 127 | 137 | 10 | int:H2AJ |
| Interaction | MEPCE interactions | H2AC11 KRT7 PUF60 DDX42 PSMC4 H2AC21 SSR4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 RBM15B H2AC7 H2AX SMARCC1 FIP1L1 H2AJ METTL16 SNRNP200 H2AC12 SYNCRIP | 1.71e-08 | 859 | 137 | 23 | int:MEPCE |
| Interaction | H3-5 interactions | 8.43e-08 | 114 | 137 | 9 | int:H3-5 | |
| Interaction | H3C15 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ H2AC12 | 1.76e-07 | 207 | 137 | 11 | int:H3C15 |
| Interaction | SSRP1 interactions | H2AC11 AAMP POLR1A POLR2E DDX42 H2AC21 MECOM PPWD1 H2AC14 H2AC4 H2AC18 H2AC20 SBF1 H2AX SMARCC1 H2AJ PRKDC SNRNP200 SYNCRIP | 2.01e-07 | 685 | 137 | 19 | int:SSRP1 |
| Interaction | H2AC20 interactions | H2AC11 HCN1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ MMP2 H2AC12 | 2.93e-07 | 320 | 137 | 13 | int:H2AC20 |
| Interaction | H2AC4 interactions | H2AC11 POLR1A H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SCML2 H2AC1 H2AC7 H2AX H2AJ PRKDC H2AC12 SYNCRIP | 3.57e-07 | 506 | 137 | 16 | int:H2AC4 |
| Interaction | CIT interactions | H2AC11 ARHGAP32 POLR1A PUF60 HCN1 POLR2E DDX42 H2AC21 ADGRV1 SSR4 RRM1 PPWD1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 SEC11A H2AC7 H2AX SMARCC1 FIP1L1 TMED2 H2AJ PRKDC SGF29 SNRNP200 SYNCRIP | 4.10e-07 | 1450 | 137 | 28 | int:CIT |
| Interaction | H2BC5 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 | 4.30e-07 | 331 | 137 | 13 | int:H2BC5 |
| Interaction | H1-2 interactions | H2AC11 COL16A1 CDC42BPA PUF60 H2AC21 MECOM RRM1 H2AC14 H2AC6 H2AC4 H2AC18 UBE2T H2AC7 H2AX CALY FIP1L1 PRKDC H2AC12 | 6.30e-07 | 666 | 137 | 18 | int:H1-2 |
| Interaction | MCM5 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ SNRNP200 H2AC12 SYNCRIP | 1.08e-06 | 420 | 137 | 14 | int:MCM5 |
| Interaction | H2BC21 interactions | H2AC11 POLR2E H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SCML2 H2AC1 MAP3K9 H2AC7 H2AX SMARCC1 H2AJ PRKDC SGF29 H2AC12 | 1.18e-06 | 696 | 137 | 18 | int:H2BC21 |
| Interaction | H2BC12 interactions | H2AC11 RRM1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.11e-06 | 322 | 137 | 12 | int:H2BC12 |
| Interaction | MACROH2A1 interactions | H2AC11 HCN1 MECOM H2AC14 H2AC4 H2AC18 H2AC20 H2AC7 H2AX SMARCC1 H2AJ SNRNP200 H2AC12 DNMT3B | 2.98e-06 | 458 | 137 | 14 | int:MACROH2A1 |
| Interaction | H2BC1 interactions | 3.63e-06 | 178 | 137 | 9 | int:H2BC1 | |
| Interaction | MCM2 interactions | H2AC11 PUF60 H2AC21 SSR4 PFN2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 TIRAP SEC11A H2AC7 H2AX H2AJ PRKDC ALDOC SNRNP200 FKBP4 H2AC12 SYNCRIP | 3.77e-06 | 1081 | 137 | 22 | int:MCM2 |
| Interaction | HNRNPD interactions | H2AC11 ARHGAP32 H2AC21 DYSF H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX SMARCC1 H2AJ H2AC12 SYNCRIP | 7.17e-06 | 638 | 137 | 16 | int:HNRNPD |
| Interaction | H3C14 interactions | 1.16e-05 | 156 | 137 | 8 | int:H3C14 | |
| Interaction | H3-4 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SEC11A H2AC7 H2AX H2AJ SGF29 H2AC12 | 1.19e-05 | 448 | 137 | 13 | int:H3-4 |
| Interaction | MIER3 interactions | 1.64e-05 | 23 | 137 | 4 | int:MIER3 | |
| Interaction | C9orf72 interactions | H2AC11 AAMP POLR1A POLR2E PSMC4 SSR4 MAGT1 RRM1 PFN2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SEC11A H2AC7 H2AX FIP1L1 H2AJ PRKDC SNRNP200 H2AC12 SYNCRIP | 2.72e-05 | 1319 | 137 | 23 | int:C9orf72 |
| Interaction | H1-6 interactions | 2.74e-05 | 229 | 137 | 9 | int:H1-6 | |
| Interaction | H2AC21 interactions | 3.25e-05 | 234 | 137 | 9 | int:H2AC21 | |
| Interaction | ELK4 interactions | 3.90e-05 | 92 | 137 | 6 | int:ELK4 | |
| Interaction | H3-7 interactions | 4.24e-05 | 137 | 137 | 7 | int:H3-7 | |
| Interaction | UBA52 interactions | H2AC11 CAPG PRRT2 MAP3K3 TXNIP H2AC14 H2AC6 H2AC4 H2AC18 H2AX B3GAT1 H2AC12 | 4.49e-05 | 437 | 137 | 12 | int:UBA52 |
| Interaction | DUOX2 interactions | 4.88e-05 | 30 | 137 | 4 | int:DUOX2 | |
| Interaction | H2BC9 interactions | H2AC11 H2AC21 ATG2A KIAA1614 H2AC14 H2AC4 H2AC18 H2AC20 H2AC7 H2AX RP1 H2AC12 | 5.46e-05 | 446 | 137 | 12 | int:H2BC9 |
| Interaction | PINK1 interactions | H2AC11 ITGA6 PFN2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AJ PRKDC SNRNP200 FKBP4 H2AC12 SYNCRIP | 6.07e-05 | 679 | 137 | 15 | int:PINK1 |
| Interaction | PRKCB interactions | 6.33e-05 | 255 | 137 | 9 | int:PRKCB | |
| Interaction | NUPR1 interactions | POLR1A NT5E POLR2E DDX42 PSMC4 H2AC21 PPWD1 MYOF H2AC6 SEC11A H2AX PRKDC SNRNP200 H2AC12 SYNCRIP | 6.48e-05 | 683 | 137 | 15 | int:NUPR1 |
| Interaction | H2BC4 interactions | 7.13e-05 | 259 | 137 | 9 | int:H2BC4 | |
| Interaction | RNF2 interactions | POLR1A POLR2E PSMC4 H2AC21 MAGT1 RRM1 DYSF H2AC4 H2AC18 H2AC20 SCML2 SEC11A H2AX SMARCC1 FIP1L1 SNRNP200 SYNCRIP | 8.28e-05 | 866 | 137 | 17 | int:RNF2 |
| Interaction | H2BC13 interactions | 9.63e-05 | 210 | 137 | 8 | int:H2BC13 | |
| Interaction | USP22 interactions | 1.09e-04 | 159 | 137 | 7 | int:USP22 | |
| Interaction | RIPOR2 interactions | 1.32e-04 | 15 | 137 | 3 | int:RIPOR2 | |
| Interaction | H2BC8 interactions | H2AC11 DDX42 H2AC21 GPKOW TBCB H2AC6 H2AC4 H2AC18 SCML2 H2AC7 H2AX SMARCC1 SGF29 | 1.56e-04 | 576 | 137 | 13 | int:H2BC8 |
| Interaction | BMI1 interactions | CAPG SSR4 MAGT1 RRM1 PPWD1 H2AC4 H2AC18 H2AC20 SCML2 H2AX SMARCC1 PRKDC SNRNP200 DNMT3B | 1.62e-04 | 659 | 137 | 14 | int:BMI1 |
| Interaction | NEK4 interactions | H2AC21 H2AC14 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AJ PRKDC ALDOC SNRNP200 H2AC12 SYNCRIP | 1.73e-04 | 582 | 137 | 13 | int:NEK4 |
| Interaction | H3-3A interactions | H2AC11 PUF60 GPKOW H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SCML2 H2AC7 H2AX SMARCC1 H2AJ PRKDC H2AC12 | 1.79e-04 | 749 | 137 | 15 | int:H3-3A |
| Interaction | H1-1 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX PRKDC H2AC12 DNMT3B | 1.82e-04 | 507 | 137 | 12 | int:H1-1 |
| Interaction | CHD4 interactions | H2AC11 PUF60 DDX42 H2AC21 MECOM NCAM2 H2AC4 H2AC20 RBM15B H2AX SMARCC1 FIP1L1 PRKDC SNRNP200 H2AC12 SYNCRIP DNMT3B | 2.15e-04 | 938 | 137 | 17 | int:CHD4 |
| Interaction | SUPT16H interactions | AAMP POLR1A MECOM H2AC4 H2AC18 H2AC20 SBF1 H2AX SMARCC1 H2AJ PRKDC | 2.22e-04 | 442 | 137 | 11 | int:SUPT16H |
| Interaction | KAT2A interactions | 2.34e-04 | 180 | 137 | 7 | int:KAT2A | |
| Interaction | GON4L interactions | 2.45e-04 | 45 | 137 | 4 | int:GON4L | |
| Interaction | APLF interactions | 2.91e-04 | 47 | 137 | 4 | int:APLF | |
| Interaction | RAD18 interactions | NT5E PER1 TXNIP H2AC4 H2AC20 H2AC1 RBM15B H2AC7 SMARCC1 FIP1L1 PRKDC | 2.95e-04 | 457 | 137 | 11 | int:RAD18 |
| Interaction | MAP1B interactions | PUF60 ITGA6 PSMC4 MECOM SSR4 TXNIP H2AC14 H2AC18 H2AC20 PRKDC ALDOC SNRNP200 | 3.18e-04 | 539 | 137 | 12 | int:MAP1B |
| Interaction | PPM1G interactions | 3.89e-04 | 325 | 137 | 9 | int:PPM1G | |
| Interaction | HMGA2 interactions | 3.94e-04 | 140 | 137 | 6 | int:HMGA2 | |
| Interaction | H3C1 interactions | H2AC11 DDX42 H2AC21 MECOM H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ PRKDC H2AC12 PDZD2 DNMT3B | 4.17e-04 | 901 | 137 | 16 | int:H3C1 |
| Interaction | METTL14 interactions | UBR1 KRT7 PUF60 H2AC6 H2AC4 H2AC1 H2AX PRKDC SNRNP200 GGPS1 H2AC12 SYNCRIP | 4.34e-04 | 558 | 137 | 12 | int:METTL14 |
| Interaction | NEB interactions | 5.27e-04 | 97 | 137 | 5 | int:NEB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 1.63e-04 | 378 | 139 | 7 | chr6p22 | |
| GeneFamily | Histones | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 5.06e-12 | 116 | 109 | 12 | 864 |
| GeneFamily | Doublecortin superfamily | 2.48e-05 | 10 | 109 | 3 | 1369 | |
| GeneFamily | Fibronectin type III domain containing | 5.21e-05 | 160 | 109 | 7 | 555 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 3.56e-04 | 5 | 109 | 2 | 1199 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.93e-04 | 24 | 109 | 3 | 654 | |
| GeneFamily | Ferlin family | 5.32e-04 | 6 | 109 | 2 | 828 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.57e-03 | 10 | 109 | 2 | 250 | |
| Coexpression | HELLER_HDAC_TARGETS_UP | H2AC11 ITGA6 PFN2 TXNIP H2AC14 H2AC6 H2AC18 SLC9A1 SBF1 H2AJ ALDOC | 1.00e-06 | 317 | 138 | 11 | M3335 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.20e-06 | 200 | 138 | 9 | M5930 | |
| Coexpression | FISCHER_DREAM_TARGETS | H2AC11 AGPAT5 H2AC21 RRM1 H2AC14 H2AC6 H2AC4 H2AC20 UBE2T H2AC7 H2AX SMARCC1 PRKDC METTL16 H2AC12 SYNCRIP DNMT3B | 1.41e-05 | 969 | 138 | 17 | M149 |
| Coexpression | REN_BOUND_BY_E2F | 1.91e-05 | 62 | 138 | 5 | M4493 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 2.28e-05 | 11 | 138 | 3 | M566 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 4.24e-05 | 37 | 138 | 4 | M16643 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 4.58e-05 | 243 | 138 | 8 | M14072 | |
| Coexpression | SANA_TNF_SIGNALING_DN | 8.80e-05 | 85 | 138 | 5 | M19467 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN | 9.16e-05 | 199 | 138 | 7 | M8289 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 9.45e-05 | 200 | 138 | 7 | M107 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 9.45e-05 | 200 | 138 | 7 | M9933 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP | 9.45e-05 | 200 | 138 | 7 | M7138 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP | 9.45e-05 | 200 | 138 | 7 | M7760 | |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN | 9.45e-05 | 200 | 138 | 7 | M7686 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 9.56e-05 | 270 | 138 | 8 | M19432 | |
| Coexpression | PIONTEK_PKD1_TARGETS_DN | 1.10e-04 | 18 | 138 | 3 | M1880 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_UP | 1.28e-04 | 92 | 138 | 5 | MM786 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_UP | 1.28e-04 | 92 | 138 | 5 | M5863 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 1.35e-04 | 93 | 138 | 5 | M4752 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.35e-04 | 284 | 138 | 8 | MM987 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | H2AC11 AGPAT5 SLC38A5 RRM1 FN3K H2AC14 H2AC4 H2AC20 UBE2T H2AC12 | 1.41e-04 | 450 | 138 | 10 | M45747 |
| Coexpression | WESTON_VEGFA_TARGETS | 1.49e-04 | 95 | 138 | 5 | M1565 | |
| Coexpression | KRIEG_HYPOXIA_NOT_VIA_KDM3A | CA9 AGPAT5 TRIOBP SIRPA MAP3K3 MYOF H2AC18 VPS13D ADPRS RBM15B PDXP SGF29 ALDOC | 1.64e-04 | 746 | 138 | 13 | M2469 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | H2AC11 ITGA6 ATG2A PFN2 TXNIP MYOF H2AC6 H2AC18 SLC9A1 ALDOC | 1.71e-04 | 461 | 138 | 10 | M14127 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | H2AC11 KRT7 COL16A1 TNC CAPG TCEAL5 SLC38A5 MECOM NCAM2 ADGRV1 PRRT2 MYOF H2AC6 H2AC4 H2AC18 THBS2 PRDM11 PDXP H2AC7 H2AX SNRNP200 H2AC12 | 2.86e-07 | 967 | 138 | 22 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | H2AC11 NR2F6 KRT7 COL16A1 MYLK TNC TCEAL5 MECOM GAL3ST4 NCAM2 ADGRV1 MYOF H2AC4 H2AC18 THBS2 H2AC20 PRDM11 H2AC7 H2AX FKBP4 H2AC12 DNMT3B | 3.18e-07 | 973 | 138 | 22 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 5.29e-07 | 108 | 138 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | H2AC11 TNC SLC38A5 MECOM NCAM2 ADGRV1 H2AC6 H2AC4 H2AC18 THBS2 PDXP H2AC7 H2AX SNRNP200 H2AC12 | 6.12e-07 | 483 | 138 | 15 | Facebase_RNAseq_e9.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 8.99e-07 | 80 | 138 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | CA9 KRT7 CRYBG2 SDK2 COL16A1 TNC NT5E CAPG ITGA6 SLC38A5 TXNIP MYOF H2AC6 IGSF22 SAA1 H2AC18 FAT2 SLC9A1 MAP3K9 H2AC7 MMP10 | 1.61e-06 | 987 | 138 | 21 | PCBC_ctl_SmallAirwayEpithel_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 2.57e-06 | 133 | 138 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.21e-06 | 137 | 138 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 7.66e-06 | 110 | 138 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.46e-05 | 236 | 138 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | KRT7 CRYBG2 COL16A1 TNC CAPG TCEAL5 MYOF H2AC18 THBS2 PRDM11 | 2.59e-05 | 298 | 138 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | H2AC11 KRT7 SDK2 COL16A1 TNC CAPG TCEAL5 SLC38A5 MECOM NCAM2 PRRT2 ALX4 H2AC14 MYOF H2AC18 THBS2 PRDM11 H2AC12 | 5.71e-05 | 968 | 138 | 18 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.27e-05 | 276 | 138 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | H2AC11 NR2F6 GAL3ST4 ADGRV1 H2AC4 H2AC18 H2AC20 H2AC7 H2AX FKBP4 H2AC12 DNMT3B | 8.93e-05 | 491 | 138 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.00e-04 | 164 | 138 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K5 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.68e-04 | 125 | 138 | 6 | JC_fibro_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.99e-04 | 244 | 138 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | KRT7 CRYBG2 COL16A1 TNC CAPG TCEAL5 MECOM NCAM2 ADGRV1 H2AC14 MYOF H2AC18 THBS2 PRDM11 PDXP H2AC12 DNMT3B | 2.03e-04 | 976 | 138 | 17 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | KRT7 SDK2 COL16A1 TNC TCEAL5 SLC38A5 ALX4 MYOF H2AC18 PRDM11 | 2.11e-04 | 384 | 138 | 10 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 2.29e-04 | 249 | 138 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_500_k-means-cluster#4 | 2.46e-04 | 86 | 138 | 5 | ratio_SC_vs_DE_500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | H2AC11 NID2 AAMP SDK2 H2AC21 ADGRV1 RRM1 ARHGEF25 TBCB H2AC6 H2AC4 H2AC18 THBS2 SEC11A PDXP H2AC7 H2AX FKBP4 DCTN3 PDZD2 | 2.78e-04 | 1298 | 138 | 20 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.45e-04 | 275 | 138 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K4 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 RRM1 H2AC6 H2AC4 H2AC20 UBE2T H2AC1 H2AC7 H2AX H2AC12 | 1.98e-11 | 188 | 139 | 11 | b240ea20750ffb825cb5fe41d06c632233406ab6 |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 RRM1 H2AC6 H2AC4 H2AC20 UBE2T H2AC1 H2AC7 H2AX H2AC12 | 2.35e-11 | 191 | 139 | 11 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 RRM1 H2AC6 H2AC4 H2AC20 UBE2T H2AC1 H2AC7 H2AX H2AC12 | 2.35e-11 | 191 | 139 | 11 | a3c5a913a99f17633c140ec9ece81b73e59e0715 |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 RRM1 H2AC6 H2AC4 H2AC20 UBE2T H2AC7 H2AX H2AC12 | 2.94e-10 | 181 | 139 | 10 | b6b41cd5d43543fe7a093033dae52a789199db0e |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 RRM1 H2AC6 H2AC4 H2AC20 H2AC1 H2AC7 H2AX H2AC12 | 4.26e-10 | 188 | 139 | 10 | be3db9768364568f44e32ae6b3bf99e49b0978bb |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | SDK2 COL16A1 MYLK TNC SLC38A5 CDH23 NCAM2 ST3GAL4 GRIK4 MMP2 | 6.72e-10 | 197 | 139 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 2.29e-09 | 111 | 139 | 8 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.18e-08 | 196 | 139 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Lymphoid-T_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 1.69e-08 | 143 | 139 | 8 | 2fbcca395971a8452f68481282a74cec4005d1e2 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 7.13e-08 | 172 | 139 | 8 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-07 | 185 | 139 | 8 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.02e-07 | 197 | 139 | 8 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-07 | 197 | 139 | 8 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-07 | 197 | 139 | 8 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.02e-07 | 197 | 139 | 8 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 2.02e-07 | 197 | 139 | 8 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.02e-07 | 197 | 139 | 8 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-07 | 197 | 139 | 8 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-07 | 197 | 139 | 8 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-07 | 199 | 139 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 2.18e-07 | 199 | 139 | 8 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-07 | 200 | 139 | 8 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.27e-07 | 200 | 139 | 8 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-07 | 200 | 139 | 8 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.27e-07 | 200 | 139 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-07 | 200 | 139 | 8 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-07 | 153 | 139 | 7 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-07 | 153 | 139 | 7 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-07 | 153 | 139 | 7 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-07 | 153 | 139 | 7 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 181 | 139 | 7 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 181 | 139 | 7 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-06 | 181 | 139 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-06 | 185 | 139 | 7 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-06 | 186 | 139 | 7 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.06e-06 | 187 | 139 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-06 | 192 | 139 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 192 | 139 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 193 | 139 | 7 | fd5a5ead966abe385a22d61a721f9fb1605876f6 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.54e-06 | 193 | 139 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 194 | 139 | 7 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 194 | 139 | 7 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-06 | 194 | 139 | 7 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-06 | 194 | 139 | 7 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 195 | 139 | 7 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 195 | 139 | 7 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-06 | 196 | 139 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-06 | 197 | 139 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.00e-06 | 198 | 139 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.10e-06 | 199 | 139 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-06 | 199 | 139 | 7 | 51be0e3a91d1f25454b56d55ef6342ef8e8df4e8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 3.10e-06 | 199 | 139 | 7 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.21e-06 | 200 | 139 | 7 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | Lung_Parenchyma-Severe|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.21e-06 | 200 | 139 | 7 | 62502bb23ca732daed32c838ce9719093f3aaeb0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.21e-06 | 200 | 139 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.21e-06 | 200 | 139 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | critical-Lymphoid-NKT-proliferating|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.21e-06 | 200 | 139 | 7 | d698458b90bf8256fe664618ef27620aa910b02a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-06 | 200 | 139 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.60e-06 | 137 | 139 | 6 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.89e-06 | 143 | 139 | 6 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.90e-06 | 147 | 139 | 6 | c0f62ed3312a33921476e89844486e09326485b7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 161 | 139 | 6 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 167 | 139 | 6 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 171 | 139 | 6 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 171 | 139 | 6 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-05 | 175 | 139 | 6 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 179 | 139 | 6 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 179 | 139 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.11e-05 | 179 | 139 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-05 | 180 | 139 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-05 | 180 | 139 | 6 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 2.32e-05 | 182 | 139 | 6 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 2.32e-05 | 182 | 139 | 6 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 2.32e-05 | 182 | 139 | 6 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 184 | 139 | 6 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 184 | 139 | 6 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 185 | 139 | 6 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 185 | 139 | 6 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 185 | 139 | 6 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 185 | 139 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 185 | 139 | 6 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 2.62e-05 | 186 | 139 | 6 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| Computational | Genes in the cancer module 89. | 2.13e-04 | 14 | 93 | 3 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 3.24e-04 | 16 | 93 | 3 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 3.90e-04 | 17 | 93 | 3 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 4.66e-04 | 18 | 93 | 3 | MODULE_552 | |
| Computational | Genes in the cancer module 18. | TNC PER1 ITGA6 PSMC4 ST3GAL4 RRM1 LSM1 THBS2 H2AX PRKDC M6PR SYNCRIP | 4.88e-04 | 451 | 93 | 12 | MODULE_18 |
| Drug | manganese | DPYS POLR1A NT5E POLR2E ITGA6 H2AC21 RRM1 ITGAX ADCY6 H2AC4 SAA1 FAT2 MGAT1 H2AC1 PDXP FES H2AX B3GAT1 H2AJ MMP2 M6PR GGPS1 | 2.09e-09 | 791 | 137 | 22 | CID000023930 |
| Drug | MgCl2 | MYLK MYO1A TNC CAPG PSMC4 H2AC21 PFN2 ADCY6 H2AC20 H2AC1 PDXP H2AX H2AJ | 2.35e-07 | 354 | 137 | 13 | CID000024584 |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | NR2F6 CDC42BPA MAP6D1 PTPN18 MAP3K6 MYOF SCML2 SMARCC1 METTL16 | 3.39e-06 | 199 | 137 | 9 | 5540_UP |
| Drug | chloride | CA9 GPHN DPYS BBS1 SLC38A5 H2AC21 PKD2L1 RRM1 ITGAX ADCY6 FN3K H2AC4 SLC9A1 H2AC1 PDXP FES H2AX H2AJ MMP2 METTL16 | 3.60e-06 | 1029 | 137 | 20 | CID000000312 |
| Drug | hydroquinone | 3.68e-06 | 201 | 137 | 9 | ctd:C031927 | |
| Drug | Berberine | 3.84e-06 | 202 | 137 | 9 | ctd:D001599 | |
| Drug | 3-acetylisoquinoline | 4.21e-06 | 6 | 137 | 3 | CID000124656 | |
| Drug | AC1O5SNJ | 4.21e-06 | 6 | 137 | 3 | CID006439900 | |
| Drug | Azone | 5.64e-06 | 20 | 137 | 4 | CID000042981 | |
| Drug | 8-bromoguanosine | 2.11e-05 | 93 | 137 | 6 | CID000092977 | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.18e-05 | 192 | 137 | 8 | 4816_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-05 | 196 | 137 | 8 | 6568_UP | |
| Drug | Prostaglandin E1; Up 200; 10uM; MCF7; HT_HG-U133A | 2.63e-05 | 197 | 137 | 8 | 6576_UP | |
| Drug | DAPH; Down 200; 10uM; MCF7; HG-U133A | 2.63e-05 | 197 | 137 | 8 | 624_DN | |
| Drug | 5194442; Down 200; 20uM; MCF7; HT_HG-U133A | 2.63e-05 | 197 | 137 | 8 | 6558_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.63e-05 | 197 | 137 | 8 | 6091_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.82e-05 | 199 | 137 | 8 | 6062_DN | |
| Drug | valerate | 3.57e-05 | 102 | 137 | 6 | CID000007991 | |
| Drug | fritillebin D | 3.59e-05 | 2 | 137 | 2 | CID005317403 | |
| Drug | AC1Q5TX2 | 3.96e-05 | 32 | 137 | 4 | CID000051716 | |
| Drug | magnesium | GPHN MYLK MYO1A TNC NT5E POLR2E BBS1 GRIK3 GRIK4 ADGRV1 RRM1 ARHGEF25 ADCY6 H2AC6 ADPRS AK5 PDXP MMP2 MMP10 GGPS1 ATP4A | 4.38e-05 | 1325 | 137 | 21 | CID000000888 |
| Drug | prinomastat | 4.48e-05 | 33 | 137 | 4 | CID000466151 | |
| Drug | fluoride | 4.86e-05 | 278 | 137 | 9 | CID000014917 | |
| Drug | A-E-C | 6.48e-05 | 70 | 137 | 5 | CID006438040 | |
| Disease | 5-dodecenoylcarnitine (C12:1) measurement | 1.96e-05 | 2 | 131 | 2 | EFO_0800555 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | hearing impairment | 7.79e-05 | 98 | 131 | 5 | C1384666 | |
| Disease | adrenoleukodystrophy (is_marker_for) | 1.94e-04 | 5 | 131 | 2 | DOID:10588 (is_marker_for) | |
| Disease | lysosomal protective protein measurement | 4.05e-04 | 7 | 131 | 2 | EFO_0008215 | |
| Disease | laurylcarnitine measurement | 4.05e-04 | 7 | 131 | 2 | EFO_0021041 | |
| Disease | toll/interleukin-1 receptor domain-containing adapter protein measurement | 4.05e-04 | 7 | 131 | 2 | EFO_0802134 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 4.05e-04 | 7 | 131 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | lateral ventricle volume measurement | 4.23e-04 | 33 | 131 | 3 | EFO_0008487 | |
| Disease | Nonsyndromic Deafness | 4.74e-04 | 81 | 131 | 4 | C3711374 | |
| Disease | cathepsin S measurement | 5.38e-04 | 8 | 131 | 2 | EFO_0008073 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 5.38e-04 | 8 | 131 | 2 | EFO_0801768 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 5.38e-04 | 8 | 131 | 2 | EFO_0801777 | |
| Disease | ceramide measurement | 6.54e-04 | 235 | 131 | 6 | EFO_0010222 | |
| Disease | Cancer of Nasopharynx | 6.90e-04 | 9 | 131 | 2 | C0238301 | |
| Disease | Nasopharyngeal Neoplasms | 6.90e-04 | 9 | 131 | 2 | C0027439 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 6.90e-04 | 9 | 131 | 2 | C3502809 | |
| Disease | tenascin measurement | 8.60e-04 | 10 | 131 | 2 | EFO_0008296 | |
| Disease | interleukin 7 measurement | 1.06e-03 | 45 | 131 | 3 | EFO_0008189 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.36e-03 | 49 | 131 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.48e-03 | 13 | 131 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.48e-03 | 13 | 131 | 2 | C1846647 | |
| Disease | skin melanoma (is_marker_for) | 1.48e-03 | 13 | 131 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.52e-03 | 51 | 131 | 3 | cv:CN043650 | |
| Disease | high grade glioma (biomarker_via_orthology) | 1.98e-03 | 15 | 131 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | hemoglobin A1 measurement | 2.30e-03 | 520 | 131 | 8 | EFO_0007629 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.43e-03 | 60 | 131 | 3 | C4722327 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.55e-03 | 61 | 131 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Disorder of eye | 2.61e-03 | 212 | 131 | 5 | C0015397 | |
| Disease | Malignant neoplasm of breast | NID2 NR2F6 PER1 H2AC21 MECOM GRIK3 DYSF MAP3K6 H2AX MMP2 MMP10 DNMT3B | 3.05e-03 | 1074 | 131 | 12 | C0006142 |
| Disease | unipolar depression, response to bupropion, mood disorder | 3.18e-03 | 19 | 131 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | hearing loss | 3.33e-03 | 67 | 131 | 3 | EFO_0004238 | |
| Disease | Prostate cancer, familial | 3.62e-03 | 69 | 131 | 3 | C2931456 | |
| Disease | transferrin glycosylation measurement | 3.89e-03 | 21 | 131 | 2 | EFO_0021537 | |
| Disease | gastric ulcer | 3.89e-03 | 21 | 131 | 2 | EFO_0009454 | |
| Disease | N-glycan measurement | 4.26e-03 | 22 | 131 | 2 | EFO_0004999 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 4.41e-03 | 74 | 131 | 3 | DOID:3748 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADTYAVVQKRGAPAG | 351 | Q99952 | |
| AGITDKGEVPNGYNV | 71 | A0A0A6YYG2 | |
| FVGGLRYEAPRVNGA | 221 | Q9P2W7 | |
| RYEAPRVNGAGKVVG | 226 | Q9P2W7 | |
| GLNGYELNGEPDRKT | 376 | Q9H161 | |
| GRYKPDTLAVAVENG | 376 | Q9H0X4 | |
| EAYIRDGGRDPGVLG | 251 | Q96LX7 | |
| GPEGGIQRYVLQAAD | 436 | Q86VW2 | |
| NVNPARKGLYEGTGR | 656 | Q9UBC3 | |
| GRVLPDGKRAVVGYE | 221 | Q13685 | |
| RAEVNGLAAQGKYEG | 331 | P09972 | |
| EPGRGGERNAYLKEQ | 531 | O43306 | |
| QGQRAHPGYLVEKGE | 961 | Q07092 | |
| RKGNYAERVGAGAPV | 36 | P0C0S8 | |
| RKGNYAERVGAGAPV | 36 | Q8IUE6 | |
| RKGNYAERVGAGAPV | 36 | Q16777 | |
| RKGNYSERVGAGAPV | 36 | Q7L7L0 | |
| RKGNYAERVGAGAPV | 36 | Q9BTM1 | |
| DPKGGARIDKVYGTA | 5601 | Q8WXG9 | |
| IDQDKGRPRGIGYTI | 261 | Q9H251 | |
| EIEADLGYPGGKARI | 2621 | Q9Y485 | |
| GEYGPKNGAERQIEE | 86 | Q2M2E5 | |
| GQQPADLREGVAKAY | 1841 | Q2TAZ0 | |
| VYRTGAKCVPGEAGD | 256 | Q9BUB4 | |
| RGTKGGVSYRPAEVA | 441 | Q16790 | |
| GLGPVKEGEAQYAVV | 266 | Q9HBZ2 | |
| GEGQVVRVKYGNADG | 216 | P08253 | |
| VVIKRPARGQGGAYA | 366 | Q8NDT2 | |
| NGVDKAGGYPRAAED | 16 | P10588 | |
| QLYVFGGGERGAQPV | 151 | Q7Z6M1 | |
| IGAPGEEENRGAVYL | 541 | P20702 | |
| SVKDGYAVRAADGPG | 371 | Q9NQX3 | |
| EVGEKFGPYVGEQRS | 101 | Q03112 | |
| AIRGNEVQAGYPRGI | 361 | P09238 | |
| EGATAKFEGRVRGYP | 46 | Q15746 | |
| GKPKRGDTYELQVRG | 146 | Q9H0U3 | |
| VAKRGVEGAYSDNPI | 571 | Q3T906 | |
| GRVLKEVYEDGQPSG | 26 | A8MXD5 | |
| DLKSGVPRAGYRGIV | 406 | P26572 | |
| RGFLIDGYPREVKQG | 456 | Q9Y6K8 | |
| DGYPREVKQGEEFGR | 461 | Q9Y6K8 | |
| VRSAYGGPVGAGIRE | 51 | P08729 | |
| VVQGPAGGDNSKLRY | 1016 | Q9UBC5 | |
| ARRDGKVVYGEPIAA | 261 | Q14117 | |
| DYINGAPRLRDAGQG | 496 | Q5VZ46 | |
| IGRTGRAGEKGVAYT | 586 | Q86XP3 | |
| VGGKRKADGYNQPDS | 561 | O60506 | |
| PEIIDQGPRGYGKAA | 816 | O95382 | |
| YGDIPRGIFVVRGEN | 56 | O15116 | |
| RKGHYAERVGAGAPV | 36 | P16104 | |
| ARGGAEPGDQVIKYV | 1111 | O15534 | |
| GGAYAAEPEENKRTR | 136 | P52945 | |
| DGPGRLAKQAFEYGI | 316 | P29122 | |
| PRVQIDVYEKGTVGG | 51 | Q8NBM8 | |
| PGAEKTGYRVVSGNE | 3246 | Q9NYQ8 | |
| RVYKGGAAEQAGIIE | 2781 | O15018 | |
| APVNLNIKTGGRVYG | 116 | Q6UN15 | |
| AERGKRLPGVAGQYL | 501 | Q86W50 | |
| GLYGKVEGLDPDNVR | 256 | Q92917 | |
| AYKQIDARGGNPELV | 271 | O95749 | |
| DNVIRKYGDPGSLFG | 31 | P23229 | |
| YIEVGEGPAALQGKF | 621 | A7KAX9 | |
| FQASRVKGYRPQGGG | 111 | Q96RP7 | |
| RKGNYAERVGAGAPV | 36 | Q6FI13 | |
| FQPGDYIIREGTIGK | 616 | Q9Y3Q4 | |
| GLLYEEKGERRGQVP | 1536 | O95248 | |
| EQVGAYEEVKRGALP | 161 | Q14112 | |
| KSQGGEPTYNVAVGR | 91 | P35080 | |
| LKPGEYGVFAARAGE | 91 | Q2TBC4 | |
| VEGGEGTQKPRDYII | 256 | Q7Z6L0 | |
| VYGPGGARGSRKVAD | 21 | O75935 | |
| PTLEGGKRIAYGARA | 351 | Q16134 | |
| FQPGDYIIREGAVGK | 496 | O60741 | |
| QDGGAPVLGYIVERR | 726 | Q8N9C0 | |
| GDGYRAAKEERKGPT | 166 | Q9NYX4 | |
| IGVYGAPHRRKETAG | 286 | A2VCK2 | |
| DALQAGGKYVAAGRE | 76 | A8MYV0 | |
| AEPLVQRGAEGDVYK | 276 | A8MYV0 | |
| GQILDVKGGRGYDRD | 1626 | Q8N1P7 | |
| DPDRGYGAGVVTVFK | 111 | Q9NX46 | |
| QGLYKADQRFGPGVE | 71 | Q9P2S6 | |
| QGYAEPEGVGDAVRA | 26 | A4D2B0 | |
| GARGVYVLPIGDADA | 111 | Q9H9H5 | |
| PRGLKYQEGGVESAF | 111 | P40121 | |
| TRGEGYAKPNEGAIV | 156 | Q02790 | |
| IRIGGIFEYADGPNA | 36 | Q13003 | |
| RLVGDGVYGVPEANG | 466 | Q16099 | |
| RKGNYAERIGAGAPV | 36 | Q96QV6 | |
| RKGNYSERVGAGAPV | 36 | P04908 | |
| RKGNYAERVGAGAPV | 36 | Q93077 | |
| RKGNYSERVGAGAPV | 36 | P20671 | |
| RKGNYAERVGAGAPV | 36 | Q96KK5 | |
| RKGNYAERVGAGAPV | 36 | Q99878 | |
| EYKLVVGDLGPGGQQ | 51 | Q8NFJ9 | |
| QEPGEKNGILTGYRI | 916 | Q58EX2 | |
| ELNTGKGEGVAYRGR | 541 | O75923 | |
| GTPEYVKFARQLAGG | 96 | P20648 | |
| EVPFRGIDGLAVAYG | 346 | P80192 | |
| PEVISGEGYGRKADV | 536 | Q99759 | |
| YKSGDPQFGGVRVVV | 41 | P56715 | |
| GVYAASGGLRQVPVK | 711 | P07332 | |
| EPLGIEEAQIGKRGY | 241 | O95602 | |
| VGSEFVQKYLGEGPR | 231 | P43686 | |
| GDPVARYFGIKRGQV | 176 | P19388 | |
| DLGGQYLRVGKAVTP | 291 | Q9UHX1 | |
| YEQLGQRAFGPAGKV | 111 | Q8WUX1 | |
| RQGKSPYKRGFDEGD | 311 | Q9NQV5 | |
| GKIFIYDGRGDNQPL | 201 | Q96BP3 | |
| NTVGRRGEGAEPQYV | 126 | Q9H479 | |
| RLNNAPVAGYEGDVG | 146 | Q11206 | |
| GAGPGRELIYNQKEG | 71 | P78324 | |
| DPQKGIGTAYEGHVR | 1076 | Q5VT25 | |
| AGLAVYRRKDGGPAT | 26 | Q92922 | |
| GGPRKADGQRQALDY | 1931 | Q9H2D6 | |
| GDGAAPRVRAVLVGY | 136 | Q96GD0 | |
| ARGNYDAAKRGPGGV | 56 | P0DJI8 | |
| DGRKVPVVQAYAFGK | 271 | P21589 | |
| VKGASGYPGAERNLL | 11 | Q8NE65 | |
| VPAAYRGVGDDQLGE | 251 | P20645 | |
| EIRVAAVNGKGQGDY | 566 | O15394 | |
| VDQGGNKRPGAFAIY | 286 | P23921 | |
| GYLKPDNRGGEVITA | 411 | Q9UQR0 | |
| LYADVGGKQFPVTRG | 66 | P51571 | |
| SGDYVARPGDKVAAR | 151 | Q96ES7 | |
| KYVVEVQVAGGAGDP | 676 | P35590 | |
| GDKSQQLGRVVVGPY | 426 | X6R8R1 | |
| YRNGDGQPKAVRVPG | 2021 | P22105 | |
| YKDRDGRPQAVRVGG | 2556 | P22105 | |
| RYDEPLGKNDGSVNG | 196 | Q99426 | |
| RGGGRGQKDLEDVPY | 191 | Q5H9L2 | |
| RPGTEYGIGVSAVKE | 956 | P24821 | |
| AQILGGANTPYEKGV | 36 | Q9NPD8 | |
| VGERYVPGVGNVTKE | 751 | Q8IWV7 | |
| PKDQFIIAYGGLRGA | 446 | P19634 | |
| KDVVGRARGFVPYIG | 136 | P67812 | |
| GVQGGQESEVPYKRE | 771 | Q9P0L9 | |
| RNELEIPGQYDGRGK | 3696 | P78527 | |
| ITGPDNKGIYKGDRE | 61 | Q15363 | |
| YVDGRGPDGGFRQVK | 196 | P58753 | |
| AGRPQYDTKGEGILI | 856 | O75643 | |
| PQYGGKACVGDVQER | 526 | P35442 | |
| YRGNQPVGVGLEAAK | 626 | P35442 | |
| VYEGKDDGGQRRESP | 231 | Q9NUQ2 | |
| DPEKVYGSGEKVAGR | 16 | Q9H3M7 | |
| GNRPGLIYNIGIDVK | 3371 | Q5THJ4 | |
| GKGEGVAYRGRILVE | 526 | Q9NZM1 |